Hangzhou Biotest Biotech Co.,Ltd. (SHA:688767)
China flag China · Delayed Price · Currency is CNY
38.92
-0.38 (-0.97%)
Apr 30, 2025, 3:00 PM CST

Hangzhou Biotest Biotech Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
4,0683,4523,2294,9287,456-
Upgrade
Market Cap Growth
48.09%6.92%-34.48%-33.91%--
Upgrade
Enterprise Value
2,4431,8451,3702,7745,736-
Upgrade
Last Close Price
38.9232.5228.9141.0759.58-
Upgrade
PE Ratio
28.4019.5430.296.378.94-
Upgrade
PS Ratio
7.936.167.302.594.10-
Upgrade
PB Ratio
1.681.451.331.923.54-
Upgrade
P/TBV Ratio
1.891.591.462.103.57-
Upgrade
P/FCF Ratio
--43.089.4010.53-
Upgrade
P/OCF Ratio
--24.587.018.21-
Upgrade
EV/Sales Ratio
4.763.293.101.463.16-
Upgrade
EV/EBITDA Ratio
-8.1749.643.595.92-
Upgrade
EV/EBIT Ratio
14.229.14370.173.695.97-
Upgrade
EV/FCF Ratio
--18.285.298.10-
Upgrade
Debt / Equity Ratio
000.000.000.010.03
Upgrade
Debt / EBITDA Ratio
-0.000.090.010.010.02
Upgrade
Debt / FCF Ratio
--0.040.020.020.03
Upgrade
Asset Turnover
0.20-0.170.731.192.05
Upgrade
Inventory Turnover
--2.306.796.033.77
Upgrade
Quick Ratio
15.60-13.2712.165.931.93
Upgrade
Current Ratio
16.74-13.9713.076.402.46
Upgrade
Return on Equity (ROE)
5.98%7.36%4.23%33.13%65.52%152.90%
Upgrade
Return on Assets (ROA)
4.20%-0.09%18.15%39.19%77.90%
Upgrade
Return on Capital (ROIC)
4.43%5.25%0.09%20.06%46.66%107.44%
Upgrade
Return on Capital Employed (ROCE)
7.10%-0.20%29.20%45.50%118.70%
Upgrade
Earnings Yield
3.58%5.12%3.30%15.70%11.18%-
Upgrade
FCF Yield
--2.32%10.64%9.50%-
Upgrade
Dividend Yield
2.57%-2.77%5.36%5.04%-
Upgrade
Payout Ratio
--220.13%41.37%2.51%23.07%
Upgrade
Buyback Yield / Dilution
-0.71%1.35%0.10%-23.15%-8.33%0.01%
Upgrade
Total Shareholder Return
1.86%1.35%2.86%-17.79%-3.29%0.01%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.